New therapies for metastatic hormone sensitive prostate cancer

As an experienced urologist and member of GU CONNECT, Prof. David Pfister provides his perspective on new therapies for mHSPC.

For additional discussion on this important topic then hear Assoc. Prof. Alicia Morgans providing her thoughts on the treatment of mHSPC and Dr. Neal Shore introducing Prof. Steven Joniau and Prof. Neeraj Agarwal summarising their view on key clinical trials in this area.